Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

New data collection vendor for CURES

Posted 1/2/2022

The California Department of Justice (DOJ) recently awarded Bamboo Health the contract for prescription data collection services for the Controlled Substance Utilization Review and Evaluation System (CURES).

You can expect to receive further instructions, including a Data Submission Guide...
Read More

Many Medicare beneficiaries are not receiving medication to treat their opioid use disorder

Posted 12/26/2021

Although nearly one million Medicare beneficiaries were diagnosed with opioid use disorder in 2020, less than 16 percent of them received the necessary medication to treat their disorder, according to a new report by the U.S....
Read More

DOJ Awards More Than $300 Million to Fight Opioid and Stimulant Crisis and to Address Substance Use Disorders

Posted 12/26/2021

The Department of Justice's Office of Justice Programs (OJP) today announced grant awards totaling more than $300 million to help combat America's substance use crisis, which has worsened during the coronavirus pandemic.

Against the backdrop of the COVID-19 pandemic, the nation is experie...
Read More

White House Announces Release of the Model Act for Expanded Access to Emergency Opioid Antagonists

Posted 12/12/2021

The White House announced the publication of a state model law for the expansion of evidence-based services to address opioid overdoses.

The Legislative Analysis and Public Policy Association developed the Model Expanded Access to Emergency Opioid Antagonists Act with a grant from the...
Read More

DEA's Agenda - Rulemaking

Posted 12/12/2021

On December 10, 2021, the Office of Information and Regulatory Affairs (OIRA) published its twice annual agenda of federal government regulations.  Included are DEA's proposed and in-process regulatory actions - found Read More

SAMHSA Extends Methadone Take-Home Flexibility for One Year

Posted 11/18/2021

Thursday, November 18, 2021 - The Substance Abuse and Mental Health Services Administration (SAMHSA) is extending the methadone take-home flexibilities for one year, effective upon the eventual expiration of the COVID-19 Public Health Emergency. This exemption is a continuation of the...
Read More

DEA Issues Advance Notice of Rulemaking for Telepharmacy

Posted 11/17/2021

The Drug Enforcement Administration (DEA) is issuing this advanced notice of proposed rulemaking to obtain further information regarding the practice of telepharmacy. Telepharmacy is not specifically defined by the Controlled Substances Act (CSA) or DEA regulations; however, to the extent telepha...
Read More

US overdose deaths topped 100,000 in one year, officials say

Posted 11/17/2021

An estimated 100,000 Americans died of drug overdoses in one year, a never-before-seen milestone that health officials say is tied to the COVID-19 pandemic and a more dangerous drug supply.

Overdose deaths have been rising for more than two decades, accelerated in the past two years and,...
Read More

Ensuring Compliance Against Drug Diversion Act of 2021 Signed into Law

Posted 11/14/2021

Washington, D.C. On November 10, 2021 President Joe Biden signed into law H.R. 1899, the "Ensuring Compliance Against Drug Diversion Act of 2021."  H.R. 1899.  H.R. 1899 amends...
Read More

DEA takes aggressive stance toward pharmacies trying to dispense addiction medicine

Posted 11/9/2021

Drug overdose deaths hit record highs last year, and despite medical experts considering medications like buprenorphine the gold standard, less than 20% of people with opioid use disorder typically receive them. The federal government has taken steps to increase the number of clinicians who...
Read More

View Earlier Announcements

Sponsor Spotlight

All Sponsors